Healthcare -
Drug Manufacturers - General - NASDAQ - GB
$ 66.6
-0.463 %
$ 207 B
Market Cap
32.17
P/E
AZN - COST OF REVENUE
Cost of Revenue AZN - AstraZeneca PLC
8.04 B
LAST VALUE
-19.60%
2 YEAR CAGR
10.25%
5 YEAR CAGR
4.33%
10 YEAR CAGR